Identification and Characterization of Microbial Metabolites in Immunity

免疫中微生物代谢物的鉴定和表征

基本信息

  • 批准号:
    10513037
  • 负责人:
  • 金额:
    $ 78.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-05-26 至 2027-04-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY The human microbiome is a key regulator of host immune function, and growing consensus suggests this relationship is likely mediated by host interactions with microbial derived small molecules (i.e., metabolites). Accordingly, microbial derived metabolites have been associated with numerous autoimmune, allergic, and infectious diseases. However, the host-microbiome circuits that form the molecular basis of these associations have not been fully characterized, and many microbial derived metabolites have not even been formally identified. In this proposal, we describe a strategy to identify and functionally characterize microbial derived metabolites isolated from patients in health and autoimmunity. Our collaborative team will isolate and characterize novel metabolites from the human microbiome, map these associations to human immune pathways, and identify the specific host receptors that engage microbial derived metabolites. This proposal will establish causal relationships between microbial metabolites and human immune system function.
项目摘要 人类微生物组是宿主免疫功能的关键调节器,越来越多的共识表明这一点 这种关系可能是由宿主与微生物衍生的小分子的相互作用介导的(即,代谢物)。 因此,微生物衍生的代谢物与许多自身免疫性、过敏性和免疫性疾病相关。 传染病然而,形成这些关联的分子基础的宿主-微生物组电路 还没有得到充分的表征,许多微生物衍生的代谢产物甚至还没有正式的 鉴定在这个建议中,我们描述了一种策略,以确定和功能特性的微生物来源, 从健康和自身免疫患者中分离的代谢物。我们的合作团队将隔离和 表征人类微生物组的新型代谢物,将这些关联与人类免疫映射 途径,并确定参与微生物衍生代谢物的特定宿主受体。这项建议会 建立微生物代谢产物和人体免疫系统功能之间的因果关系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel Bartholomew Graham其他文献

Daniel Bartholomew Graham的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel Bartholomew Graham', 18)}}的其他基金

Identification and Characterization of Microbial Metabolites in Immunity
免疫中微生物代谢物的鉴定和表征
  • 批准号:
    10629379
  • 财政年份:
    2022
  • 资助金额:
    $ 78.31万
  • 项目类别:
Systematic dissection of gut cellular circuits [at single cell resolution]
肠道细胞回路的系统剖析[单细胞分辨率]
  • 批准号:
    9380153
  • 财政年份:
    2017
  • 资助金额:
    $ 78.31万
  • 项目类别:
Systematic dissection of gut cellular circuits [at single cell resolution]
肠道细胞回路的系统剖析[单细胞分辨率]
  • 批准号:
    9753218
  • 财政年份:
    2017
  • 资助金额:
    $ 78.31万
  • 项目类别:

相似海外基金

Elucidating the Role of Cutaneous Environmental Factors in the Development of Allergic Disease
阐明皮肤环境因素在过敏性疾病发展中的作用
  • 批准号:
    10664255
  • 财政年份:
    2023
  • 资助金额:
    $ 78.31万
  • 项目类别:
Regulatory mechanism of allergic disease development by inhibitory co-receptors
抑制性共受体对过敏性疾病发生的调控机制
  • 批准号:
    22H02888
  • 财政年份:
    2022
  • 资助金额:
    $ 78.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
  • 批准号:
    10633229
  • 财政年份:
    2022
  • 资助金额:
    $ 78.31万
  • 项目类别:
Deep Phenotyping of Allergic Disease and Environmental Allergen Component Sensitization
过敏性疾病的深层表型分析和环境过敏原成分致敏
  • 批准号:
    22K10545
  • 财政年份:
    2022
  • 资助金额:
    $ 78.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of the prevalence, presentation and immunologic features of the α-Gal syndrome in a high-risk cohort not recruited on the basis of allergic disease
未根据过敏性疾病招募的高危人群中 α-Gal 综合征的患病率、表现和免疫学特征的调查
  • 批准号:
    10670058
  • 财政年份:
    2022
  • 资助金额:
    $ 78.31万
  • 项目类别:
Elucidation of immune and allergic disease dynamics by integrative sequencing analysis
通过整合测序分析阐明免疫和过敏性疾病动态
  • 批准号:
    22H00476
  • 财政年份:
    2022
  • 资助金额:
    $ 78.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Investigation of the prevalence, presentation and immunologic features of the α-Gal syndrome in a high-risk cohort not recruited on the basis of allergic disease
未根据过敏性疾病招募的高危人群中 α-Gal 综合征的患病率、表现和免疫学特征的调查
  • 批准号:
    10353468
  • 财政年份:
    2022
  • 资助金额:
    $ 78.31万
  • 项目类别:
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
  • 批准号:
    10535286
  • 财政年份:
    2022
  • 资助金额:
    $ 78.31万
  • 项目类别:
Humoral Immunoregulation of Allergic Disease by Follicular T Cell Subsets
滤泡 T 细胞亚群对过敏性疾病的体液免疫调节
  • 批准号:
    10570227
  • 财政年份:
    2021
  • 资助金额:
    $ 78.31万
  • 项目类别:
Investigating the effect of maternal microbiome on fetal hematopoiesis and subsequent susceptibility to allergic disease
研究母体微生物组对胎儿造血和随后对过敏性疾病的易感性的影响
  • 批准号:
    467169
  • 财政年份:
    2021
  • 资助金额:
    $ 78.31万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了